Related Articles
Astragaloside IV ameliorates necrotizing enterocolitis by attenuating oxidative stress and suppressing inflammation via the vitamin D3-upregulated protein 1/NF-κB signaling pathway
Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway Corrigendum in /10.3892/mmr.2021.12547
Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo
Astragaloside IV suppresses inflammatory mediator production in synoviocytes and collagen‑induced arthritic rats
Anticancer effects and mechanisms of astragaloside‑IV (Review)